Solitaire

Solitaire Therapeutics is an early-stage biotechnology company focused on developing novel small molecule therapies for orphan and rare diseases. The company leverages deep expertise in medicinal chemistry and disease biology to target high-unmet-need indications that currently lack effective treatment options. While much of its specific pipeline remains in stealth or pre-clinical development, Solitaire aims to advance precision medicines that address the underlying genetic or biochemical drivers of rare conditions. The leadership team consists of industry veterans with a track record of successful drug discovery and development in the orphan drug space.